Desk› Healthcare› Onesource Specialty Pharma Ltd
Onesource Specialty Pharma Ltd
Filing rhythm · 60 trading days
14 filings · 6 material · busiest 2026-07-24
What it files
Filings
14 in the window
-
18 August 2026
Credit RatingCredit Rating
Intimation of Credit Rating issued by India Ratings and Research Private Limited vide press release dated August 17, 2026
Company Update / Credit Rating View filing →
-
31 July 2026
Concall TranscriptEarnings Call Transcript
Intimation of Transcript of Earnings call dated July 25, 2026
Company Update / Earnings Call Transcript View filing →
-
27 July 2026
Change in ManagementChange in Management
Changes in Senior Management Personnel (SMP) of the Company - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Company Update / Change in Management View filing →
-
24 July 2026
Board OutcomeBoard Meeting Outcome for Intimation Of The Outcome Of The Board Meeting Dated July 24, 2026, For The Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026
Outcome of the Board meeting dated July 24, 2026, for the approval of the unaudited financial results (Standalone and Consolidated) for the quarter ended June 30, 2026.
Board Meeting / Outcome of Board Meeting View filing →
-
24 July 2026
Change in ManagementChange in Management
Changes in the Senior Managament Personnel of the Company-Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Company Update / Change in Management View filing →
-
24 July 2026
Press ReleasePress Release / Media Release
OneSource announces strong Q1FY27 results Revenue up 37% YoY and EBITDA up 39% YoY
Company Update / Press Release / Media Release View filing →
-
24 July 2026
ESOP AllotmentAllotment of ESOP / ESPS
Intimation of allotment of 2,900 ESOPs of Re.1 each under ONESOURCE ESOP 2021
Company Update / Allotment of ESOP / ESPS View filing →
-
21 July 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Intimation of Earnings Call to be held on July 25, 2026.
Company Update / Analyst / Investor Meet View filing →
-
20 July 2026
Board MeetingBoard Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter Ended June 30, 2026.
Onesource Specialty Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 ,inter alia, to consider and approve Unaudited financial ....
Board Meeting / Board Meeting View filing →
-
14 July 2026
General544292 - Onesource Specialty Pharma And Formycon AG Announce Strategic Manufacturing Partnership For Biosimilars
OneSource Specialty Pharma and Formycon AG announce Strategic Manufacturing Partnership for Biosimilars
Company Update / General View filing →
-
9 July 2026
GeneralIntimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015
We refer to the intimation made earlier today by Dr. Reddy's Laboratories (DRL) regarding delay in commercial supplies of Semaglutide. Refer intimation attached.
Company Update / General View filing →
-
8 July 2026
ESOP AllotmentAllotment of ESOP / ESPS
Allotment of 24,190 equity shares of Re. 1/- under ONESOURCE ESOP 2021 on July 08, 2026.
Company Update / Allotment of ESOP / ESPS View filing →
-
2 July 2026
GeneralCompletion Of US-FDA Inspection At Sterile Product Division (SPD) Facility At Bengaluru
We wish to inform that a routine current Good Manufacturing (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the Sterile Product Division facility ....
Company Update / General View filing →
-
24 June 2026
Trading WindowClosure of Trading Window
Intimation of closure of Trading window for declaration of unaudited financial results for the quarter ended June 30, 2026.
Insider Trading / SAST / Closure of Trading Window View filing →